甲状旁腺激素与碱性磷酸酶升高与非透析依赖性慢性肾脏病骨折风险相关
该研究基于丹麦全国45,611例非透析依赖性CKD G3-5成人,分析PTH和ALP与骨折风险的关系。结果显示高PTH(2.1-4.0倍正常上限)及极高PTH(≥4.0倍)与主要骨质疏松性骨折风险增加相关;ALP从正常上限到升高均与主要骨质疏松性骨折风险增加相关,任何骨折结果类似。
要点
- 高PTH(2.1-4.0倍正常上限)和极高PTH(≥4.0倍)与主要骨质疏松性骨折风险增加相关。
- ALP处于正常上限、轻度升高和高水平均与主要骨质疏松性骨折风险增加相关。
- PTH和ALP对任何骨折的风险关联与主要骨质疏松性骨折相似。
核心结论
- 在非透析依赖性CKD G3-5患者中,PTH和ALP水平与骨折风险呈正相关。
研究设计与样本
- 丹麦全国观察性队列研究,纳入2010至2022年eGFR<60 ml/min/1.73 m2且测量过PTH的成人45,611例。
- PTH按检测正常上限(UNL)分层为正常、轻度升高(1.1-2.0×UNL)、高(2.1-4.0×UNL)和极高(≥4.0×UNL)。
- ALP分层为低至低正常(<70 U/L)、正常上限(70-105 U/L)、轻度升高(106-125 U/L)和高(>125 U/L)。
- 采用多变量Cox回归模型估计主要骨质疏松性骨折(MOF)和任何骨折的发生率,并调整相关混杂因素。
主要发现
- 与PTH正常者相比,高PTH者MOF的HR为1.15(95%CI 1.04-1.26,p=0.005),极高PTH者HR为1.23(95%CI 1.04-1.46,p=0.012)。
- 与ALP低至低正常者相比,ALP正常上限者MOF的HR为1.11(95%CI 1.02-1.20,p=0.01),轻度升高者HR为1.29(95%CI 1.13-1.47,p<0.001),高者HR为1.59(95%CI 1.39-1.75,p<0.001)。
- 按ALP和PTH分层分析任何骨折事件,得到的HR与MOF相似。
关键数值与推荐
- 高PTH定义为2.1-4.0倍正常上限,极高PTH定义为≥4.0倍正常上限。
- ALP分层界值:<70 U/L、70-105 U/L、106-125 U/L、>125 U/L。
- MOF包括髋部、椎体、腕部和肱骨骨折。
临床怎么用
- 在非透析依赖性CKD G3-5患者中,可考虑检测PTH和ALP以帮助识别骨折高风险人群。
- 对PTH超过正常上限2倍或ALP高于70 U/L的患者,应加强骨折风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We studied over 45,000 Danish adults with non-dialysis-dependent chronic kidney disease to assess whether parathyroid hormone (PTH) and alkaline phosphatase (ALP) were associated with fracture risk. Elevated PTH (over twice normal) and ALP (above 70 U/L) were linked to higher fracture rates, suggesting these markers may help identify high-risk patients. PURPOSE: Patients with chronic kidney disease (CKD) have an increased risk of bone fracture. We aimed to examine the association between parathyroid hormone (PTH), alkaline phosphatase (ALP), and fracture risk in non-dialysis-dependent CKDG3-5. METHODS: Danish adults with eGFR < 60 ml/min/1.73 m2 and measured PTH were identified from nationwide healthcare registers between 2010 and 2022. PTH was standardized to the assay-specified upper normal limit (UNL) and stratified as normal, slightly elevated (1.1-2.0 × UNL), high (2.1-4.0 × UNL), and very high (≥ 4.0 × UNL). ALP was stratified as low to low-normal (< 70 U/L), upper-normal (70-105 U/L), slightly elevated (106-125 U/L), and high (> 125 U/L). Rates of major osteoporotic fracture (MOF; hip, vertebra, wrist, and humerus fracture) and any fracture were estimated in multiple Cox regression models adjusted for relevant confounders. RESULTS: Among 45,611 included individuals adjusted rates of MOF were increased in patients with high PTH (hazard ratio (HR) 1.15, 95% confidence interval (CI) 1.04-1.26, p = 0.005) and very high PTH (HR 1.23, 95% CI 1.04-1.46, p = 0.012), compared to patients with normal PTH. Patients with ALP levels in the upper-normal (HR 1.11, CI 1.02-1.20, p = 0.01), slightly elevated (HR 1.29 CI 1.13-1.47, p < 0.001), and high (HR 1.59, CI 1.39-1.75, p < 0.001) categories showed significantly higher rates of MOF compared to low to low-normal ALP. We found similar HRs of any fracture event stratified by ALP- and PTH levels. CONCLUSION: Our nationwide observational cohort study demonstrates that PTH and ALP were positively associated with fracture risk in non-dialysis-dependent CKDG3-5.
引用
- Pichat CSH, Ballegaard ELF, Bressendorff IO, et al. Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease. Osteoporos Int. 2026. PMID: 42020816. doi:10.1007/s00198-026-08035-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。